| Term 
 | Definition 
 
        | -Rifamycin binding near the active site of RNA polymerase -Antimicrobial agents: RNA polymerase inhibitors
 -Bactericidal
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Macrocyclic antibiotics that inhibit DNA-dependent RNA polymerase, Bactericidal |  | 
        |  | 
        
        | Term 
 
        | Rifampin (Rifadin) and rifabutin (Mycobutin) |  | Definition 
 
        | extremely effective antibiotics against both gram positive and gram negative organisms, including strains of Staphylococcus (Staph) aureus (including Methicillin Resistant S. aureus
 [MRSA], Pseudomonas, Klebsiella, Proteusetc.
 |  | 
        |  | 
        
        | Term 
 
        | Rifampin (Rifadin) is very effective against mycobacteria especially: |  | Definition 
 
        | Mycobacterium tuberculosis (rifampin), as well as M. aviae |  | 
        |  | 
        
        | Term 
 
        | rifabutin (Mycobutin) is Very effective against |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | rifabutin (Mycobutin) is Very effective against |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Rifampin (Rifadin) and rifabutin (Mycobutin) bind to beta subunit of bacterial enzyme but do not bind to: |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Rifampin (Rifadin) and rifabutin (Mycobutin)  are administered most often in combination with: |  | Definition 
 
        | -isoniazid in thetreatment of tuberculosis—first line treatment -Combination therapy prevents emergence of resistant tubercle bacilli
 |  | 
        |  | 
        
        | Term 
 
        | Rifampin (Rifadin) and rifabutin (Mycobutin) are used in the prophylaxis against: |  | Definition 
 
        | meningococcal disease—Penetrate into the CNS |  | 
        |  | 
        
        | Term 
 
        | Rifampin and Rifabutin are potent stimulators of microsomal enzymes: |  | Definition 
 
        | - They decrease half life of other drugs—Drug-Drug interaction. -Cause discoloration of urine and tears—Patients should be warned not to wear contact lenses during rifamycin treatment
 |  | 
        |  | 
        
        | Term 
 
        | Side Effects of Rifampin and Rifabutin |  | Definition 
 
        | Hepatitis (1%) or leukopenia and thrombocytopenia (rifabutin) |  | 
        |  | 
        
        | Term 
 
        | Antimicrobial agents: Protein synthesis inhibitors |  | Definition 
 
        | Aminoglycosides, tetracyclines
 glycylcyclines,
 chloramphenicol
 lincosamides,
 streptogramins
 oxazolidinone
 macrolide
 ketolide antibiotics
 |  | 
        |  | 
        
        | Term 
 
        | Drugs or drug class targeting 30s ribosomal subunits: |  | Definition 
 
        | -Aminoglycosides -Spectinomycins
 -Tetraciclines
 The side of action of these drugs is 16s rRNA.
 |  | 
        |  | 
        
        | Term 
 
        | Mechanism of action of aminoglycoside: |  | Definition 
 
        | Induce misreading, halt protein synthesis at higher concentration. |  | 
        |  | 
        
        | Term 
 
        | Mechanism of action of Spectinomycin |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mechanism of action of Tetracycline |  | Definition 
 
        | Inhibit aminoacyl tRNA binding to A site. |  | 
        |  | 
        
        | Term 
 
        | Drugs or drug class targeting 50s ribosomal subunit: |  | Definition 
 
        | -Microlide -Lincosimides
 -Chloramphenicol
 -Streptogramins
 -Oxazolidinones
 The side of action of these drugs is 23s rRNA
 |  | 
        |  | 
        
        | Term 
 
        | Mechanism of action of Microlides: |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mechanism of action of Chloramphenicol |  | Definition 
 
        | Inhibit peptidyl transferase by interfering with the tRNA positionning. |  | 
        |  | 
        
        | Term 
 
        | Mechanism of action of Lincosimides |  | Definition 
 
        | inhibit peptidyl transferase by blocking the growing polypeptide chains and by inhibiting A and P sites |  | 
        |  | 
        
        | Term 
 
        | Mechanism of action of Streptogramins: |  | Definition 
 
        | Inhibit peptidyl transferase; Probable overlap with mechanism  of action of Microlides;
 |  | 
        |  | 
        
        | Term 
 
        | Mechanism of action of oxazilidinones: |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | First in class of Aminoglycosides: Bactericidal protein synthesis inhibitors |  | Definition 
 
        | streptomycin (1944),then neomycin, kanamycin (Kantrex),
 |  | 
        |  | 
        
        | Term 
 
        | The 3 most widely used because of higher potency and lower toxicity drug in aminoglycoside class: |  | Definition 
 
        | gentamicin (Garamycin) (1963)**,tobramycin (Nebcin)**, amikacin (Amikin)**
 |  | 
        |  | 
        
        | Term 
 
        | the drug of choice for many gram negative infections, e.g.urinary tract infections, pneumonia, sepsis, meningitis, peritonitis |  | Definition 
 
        | is Gentamicin Side Effects: Nephrotoxicity and ototoxicity [mitochondrial metabolic
 block] limits the usefulness of streptomycin but especially kanamycin (8-26% patients develop these)
 |  | 
        |  | 
        
        | Term 
 
        | What drugs combination is used  in the treatment of streptococci or enterococci ? |  | Definition 
 
        | Combinations of penicillin or vancomycin plus streptomycin or gentamicin |  | 
        |  | 
        
        | Term 
 
        | the most active aminoglycoside against Pseudomonasor Proteus is: |  | Definition 
 
        | Tobramycin . Low level of penetration of amino glycosides in CNS and moderate level of penetration in lungs—difficulty in use as monotherapies
 |  | 
        |  | 
        
        | Term 
 
        | Resistance to aminoglycosides develops: |  | Definition 
 
        | metabolic conversion of the active molecule of the aminoglycoside by transferases, for example acetylation—Plasmid-mediated genetic transmission of resistance—oraltered porin structure or 30S ribosome structure mutation
 |  | 
        |  | 
        
        | Term 
 
        | Capreomycin- Bacteriostatic |  | Definition 
 
        | is a 30s subunit protein synthesis inhibitor re-introduced for the treatment of tuberculosis with multiple drug resistance.  Toxicity is a major problem
 |  | 
        |  | 
        
        | Term 
 
        | Spectinomycin—Bacteriostatic |  | Definition 
 
        | Structural analog of Aminoglycosides but binds at different site on 16S rRNA of 30S subunit Permits formation of 70S complex
 Inhibits protein synthesis
 No misreading of mRNA and no inappropriate protein synthesis
 Alternative therapy of gonorrhea (Neisseria gonorrheae) infections
 
 Administered as an injectable—No serious side-effects
 |  | 
        |  | 
        
        | Term 
 
        | Tetracyclines and Glycylcyclines—Broad spectrum, bacteriostatic protein synthesis inhibitors |  | Definition 
 
        | Site of action is protein synthesis, in particular the binding of charged t-RNA More selective for bacterial protein synthesis
 First of the truly broad spectrum antibiotics—effective against atypicalas well as typical pathogens:
 |  | 
        |  | 
        
        | Term 
 
        | Doxycycline is not as good against |  | Definition 
 
        | S. aureus, S. pneumoniae but tigecycline is |  | 
        |  | 
        
        | Term 
 
        | Resistance to tetracyclines has limited their use as broadspectrum antimicrobials—except for newest entry: |  | Definition 
 
        | -the tigecycline (an IV drug) -Tigecycline is effective as treatment of multi-drug resistant (MDR) gram negative organisms such as Pseudomonas aureginosa, Klebsiella, and Acetinobacter baumannii—80-85% effective
 |  | 
        |  | 
        
        | Term 
 
        | Tigecyline is also effective against : |  | Definition 
 
        | -Vancomycin Resesistant Enterococcus (VRE) infections and MRSA -FDA  approved Tigecycline for the treatment of complicated skin and
 skin structure infections (cSSI), complicated intra-abdominal infections(cIAI), and community acquired pneumonias (CAP)
 |  | 
        |  | 
        
        | Term 
 
        | Side effects of tetracyclines: |  | Definition 
 
        | Interactions of tetracyclines with divalent cations—Ca2+ (bone/tooth accumulation & discoloration); kidney damage and GI distress
 |  | 
        |  | 
        
        | Term 
 
        | Macrolide antimicrobials are bacteriostatic protein synthesis inhibitors
 |  | Definition 
 
        | Introduced in the 1950's--include erythromycin (E-mycin),azithromycin (Zithromax), clarithromycin (Biaxin), and telithromycin (Ketek)
 -Useful in the treatment of pulmonary infections, including
 Legionnaires’ disease (pneumonia) -Bacteriostatic, not to be used in treating conditions requiring
 bactericidal activity, e.g., osteomyelitis, endocarditis, meningitis
 -Most useful in the treatment of streptococcal infections, especially in individuals hypersensitive to penicillins—few if any resistant
 streptococci to erythromycin
 -Dosage varies from 500 mg/d (azithromycin, Z-pak and Z-max) to
 500 mg/6h (erythromycin)—different PK characteristics
 |  | 
        |  | 
        
        | Term 
 
        | Other conditions treated with erythromycin: |  | Definition 
 
        | Mycoplasma pneumoniae, Chlamydia,
 diphtheria,
 whooping cough (pertussis),tetanus,
 acute syphilis and
 gonorrhea
 |  | 
        |  | 
        
        | Term 
 
        | What combination drugs is use in the treatment of Helicobacter pylori—peptic ulcer disease? |  | Definition 
 
        | clarithromycin, lansoprazole and amoxicillin (Prevpac) |  | 
        |  | 
        
        | Term 
 
        | Chloramphenicol—Bacteriostatic and bactericidal protein synthesis inhibitor
 |  | Definition 
 
        | Chloramphenicol (Chloromycetin) binds to 50 S ribosome and inhibits transpeptidase reaction, blocks elongation of protein chain
 2. Also causes inhibition of mitochondrial
 ribosomes in eukaryotic cells
 3. Resistance due primarily to the
 expression of plasmid-encoded
 acetyl transferases—drug inactivation
 Introduced in 1948—Broad spectrum against gram + and gram –
 bacteria, both aerobic and anaerobic
 -H. influenzae, Neisseria meningitides, Bacteroides
 -Is not used much because of severe toxicity, in particular aplastic
 anemia, hypoplastic anemia, agranulocytosis and thrombocytopenia,i.e., partial or complete shutdown of the bone marrow
 -1 in 30,000 doses administered associated with bone marrow
 problems
 -Drug interactions with: phenytoin, warfarin (prolongation of activity)
 |  | 
        |  | 
        
        | Term 
 
        | Lincosamides—Clindamycin, Bacteriostatic |  | Definition 
 
        | -Clindamycin (Cleocin) used for severe anaerobic infections— Bacteroides
 -Blocks peptide bond formation—interacts with both A and P site
 and resembles in its actions both chloramphenicol and macrolides
 -Causes Pseudomembranous colitis as a result of Clostridium
 difficile growth in the GI
 -Beware of inducible resistance during treatment by this
 antimicrobial or macrolides or streptogramin
 -Used in the treatment of fasciitis, skin/soft tissue infections, and
 intra-abdominal infections with anaerobic bacteria—Normal dosage:300 mg/6h
 |  | 
        |  | 
        
        | Term 
 
        | Streptogramins, Quinupristin/Dalfopristin (Synercid)—Bactericidalagainst most sensitive bacteria |  | Definition 
 
        | Approved (1999) for the treatment of Enterococcus faecium and Streptococcus pyogenes;
 
 
 Approved for the treatment of Vancomycin-resistant enterococci
 (faecium) [VRE] and for methicillin resistant S. aureus [MRSA] and
 Streptococcus pyogenes
 
 
 23S rRNA/ 50S ribosome binding—Inhibition of peptidyl transferase and emergence of growing peptide chain
 
 
 ―Irreversible‖ inhibition of 50S subunit
 |  | 
        |  | 
        
        | Term 
 
        | Oxazolidinones—Linezolid (Zyvox) |  | Definition 
 
        | Exact site of action not known but suspected to be 23SrRNA 
 
 Effective against MRSA, penicillin-resistant
 Streptococci, and vancomycin-resistant Enterococci
 (VRE)
 
 
 
 Useful in the treatment of Multi-Drug Resistant
 organisms such as A. baumannii
 |  | 
        |  |